It’s a combination of cool, but early stage, research, combined with a perceived need to hype potential future capabilities to attract funding. Fairly common academic strategy where “thing” exists as a potentially enabling technology, but is not anywhere near commercialization.
In this particular case, what they have developed is actually pretty cool from multiple perspectives: long-lasting neuronal organoids in microfluidic devices, a remote orchestration system to do wetware expts, and an ability to parallelize experiments.
In their paper,
https://www.frontiersin.org/ar...
they describe it as a tool to enable research experimentation at the scale that would be needed to design an actual computing framework using biological neural nets. So they are advertising this as a collaborative platform for researchers who don’t have the expertise to develop and run microfluidic tissue experiments in their own labs.
The Neuroplatform enables researchers to run experiments on neural organoids with a lifetime of even more than 100 days. To do so, we streamlined the experimental process to quickly produce new organoids, monitor action potentials 24/7, and provide electrical stimulations. We also designed a microfluidic system that allows for fully automated medium flow and change, thus reducing the disruptions by physical interventions in the incubator and ensuring stable environmental conditions. Over the past three years, the Neuroplatform was utilized with over 1,000 brain organoids, enabling the collection of more than 18 terabytes of data.
Sounds pretty useful to me, but probably never commercializable on its own.